Hikma enters settlement agreement with Jazz to sell Xyrem generic
07-04-2017
Hikma launches generic Xeloda in the US
21-07-2016
Igorgolovniov / Shutterstock.com
Hikma Pharmaceuticals has secured a win in its “skinny label” patent suit with Amarin Pharmaceuticals, following a ruling handed down by a federal court in the state of Delaware.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Hikma Pharmaceuticals, Amarin Pharmaceuticals, Vascepa, generics
